CompletedNCT05161351
Baclofen safety research with people receiving methadone
About this title
Read the official source — NCT05161351Medication studyAges 21+United KingdomAddiction
Understand this study
Who was this study for?
Listed age limits: from 21 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: July 23, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- Imperial College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom
- Age range
- Over 21 Years
- Official registry ID
- NCT05161351
- Official title
Show the full official title
Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. An Adaptive, Single-blind, Placebo-controlled Ascending Dose Study of Acute Baclofen on Safety Parameters in Opioid Dependence During Methadone-maintenance Treatment; a Pharmacokinetic-pharmacodynamic Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London, a university.
Did this study involve medication?
Yes. The study involved medication, including Baclofen and Vitamin D3.
Who was this study for?
Listed age limits: from 21 years.
